(a) Periodic disclosure and updating of information by each approved person on his actual and potential conflicts of interest; and

(b) Advance approval by directors or shareholders who do not have an interest in the transactions in which an insurance licensee's approved person has a personal interest. The Board should require such advance approval in every case.